RECENT PLACEMENT

Occam Recruits Sapna Srivastava to the Board of Nuvalent

Occam Recruits Sapna Srivastava to the Board of Nuvalent

Nuvalent, an F-Prime/Deerfield investment, develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events and drive more durable responses. The company went public in 2021 generating $166M.

In late 2021, Occam recruited Sapna Srivastava, PhD to the Board of Nuvalent. Sapna began her career as an equity analyst on Wall Street before taking on operating CFO roles at innovative biotechs like eGenesis, VelosBio, and Intellia.

Recent Placements

  1. John Reynders as Chief Data Sciences Officer of Neumora
  2. Jevan Soo Lenox as Chief People Officer at insitro
  3. Jorge Bartolome as CEO at Areteia Therapeutics
  4. Kevin Coveney as CFO of Enveric Biosciences
  5. Gurpreet Ratra as CBO at Skyline
About Occam Global

Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors.  Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression.  Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences.  Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.